PUNAM MALIK, MD
Medical Practice in Cincinnati, OH

License number
Ohio 35.091275
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
3333 Burnet Ave. Ml, Cincinnati, OH 45229
Phone
(513) 636-4266
(513) 636-3549 (Fax)

Personal information

See more information about PUNAM MALIK at radaris.com
Name
Address
Phone
Punam Malik, age 63
4073 Egbert Ave, Cincinnati, OH 45220

Organization information

See more information about PUNAM MALIK at bizstanding.com

Punam Malik MD

3333 Burnet Ave #ML7015, Cincinnati, OH 45229

Industry:
Pediatric Oncologist, Pediatrician
Doing business as:
Punam Malik MD,MBBS,BS
Phone:
(513) 636-4266 (Phone)
Punam Malik
Categories:
Hospitals, Physicians & Surgeons

Professional information

Punam Malik Photo 1

Punam Malik, Cincinnati OH

Specialties:
Pediatric Hematologist / Oncologist
Address:
3333 Burnet Ave, Cincinnati, OH 45229
Education:
Bachelor of Medicine, Bachelor of Surgery*
Board certifications:
American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)*


Punam Malik Photo 2

Punam Malik, Cincinnati OH

Specialties:
Pediatric Hematology & Oncology
Address:
Cincinnati Childrns Hosp Cancer
3333 Burnet Ave SUITE 7015, Cincinnati 45229
(513) 636-4266 (Phone)
Certifications:
Pediatric Oncology & Pediatric Hematology, 2000, Pediatrics, 1998
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Delhi / College of Medical Sciences
Children's Hospital Of L A


Punam Malik Photo 3

Optimization Of Determinants For Successful Genetic Correction Of Diseases, Mediated By Hematopoietic Stem Cells

US Patent:
2011029, Dec 1, 2011
Filed:
Dec 6, 2010
Appl. No.:
12/928302
Inventors:
Johannes Christiaan Maria Van Der Loo - Loveland OH, US
Dao Pan - Cincinnati OH, US
Punam Malik - Cincinnati OH, US
Assignee:
Cincinnati Children's Hospital Medical Center - Cincinnati OH
International Classification:
C12Q 1/68, C07H 21/00, C12N 15/63
US Classification:
435 61, 4353201, 536 241
Abstract:
Methods and compositions disclosed herein generally relates to methods of determining minimum hematopoietic stem cell (HSC) chimerism and gene dosage for correction of a hematopoietic disease; in particular, in in vivo models. The invention also relates to modified lentiviral expression vectors for increase a viral titer and various methods for increasing such titers as well as expression vectors capable of enhancing such titers. The invention also relates to CHS4 chromatin insulator-derived functional insulator sequences. The invention further relates to methods for genetic correction of diseases or reducing symptoms thereof, such as sickle cell anemia, a lysosomal storage disease. The invention further relates to a method of improving and/or correcting one or more central nervous system (CNS) abnormalities caused by one or more lysosomal storage disease. The invention further relates to methods of improving titer in transfection-based bioreactor culture production or transfection-based production systems using eukaryotic cells.